Insulin resistance and hepatitis C

doi:10.3748/wjg.v12.i44.7075

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 44

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3644)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

280

HTML

3131

Figures (1-2)

233

Sum=3644

Nov 28, 2006 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (117)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Nov 28, 2006; 12(44): 7075-7080
Published online Nov 28, 2006. doi: 10.3748/wjg.v12.i44.7075

Open in New Tab Full Size Figure Download Figure

Figure 1 Prevalence of type 2 diabetes mellitus in patients with chronic hepatitis C and chronic hepatitis B.

Open in New Tab Full Size Figure Download Figure

Figure 2 Interaction between insulin and peginterferon alpha signalling pathway. The phosphatidil-inositol-3-kinase (PI3K) activated by insulin seems to be responsible for the block of STAT 1 translocation avoiding antiviral effect of interferon. Dotted lines represent inhibition, continuous lines represent activation.

Citation: Romero-Gómez M. Insulin resistance and hepatitis C. World J Gastroenterol 2006; 12(44): 7075-7080
URL: https://www.wjgnet.com/1007-9327/full/v12/i44/7075.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i44.7075